Dolsten Mikael Insider Trades

Insider Trading History

Track insider trading activity for Dolsten Mikael. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.58M 38,447 shares
$41.03
$41.03
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $0 0 shares
Last Trade
May 14, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$587k 14,312 shares
$41.03
$41.03
Agilent Technologies
Agilent Technologies A
Director
Holding Value $988k 7,138 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$241k 2,158 shares
$111.75
$138.36
Apellis Pharmaceuticals
Apellis Pharmaceuticals APLS
Director
Holding Value $990k 24,135 shares
Last Trade
Feb 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$806k 38,447 shares
$20.96
$41.03
Agilent Technologies
Agilent Technologies A
Director
Holding Value $688k 4,973 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$390k 2,600 shares
$149.81
$138.36
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $129k 44,220 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$84.9k 30,000 shares
$2.83
$2.92
Agilent Technologies
Agilent Technologies A
Director
Holding Value $1.04M 7,549 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$220k 1,819 shares
$121.18
$138.36
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $41.5k 14,220 shares
Last Trade
Mar 05, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$131k 14,220 shares
$9.21
$2.92
Pfizer
Pfizer PFE
President R&d
Holding Value $0 0 shares
Last Trade
Sep 12, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$7.71M 264,554 shares
$29.16
$25.69
Pfizer
Pfizer PFE
President R&d
Holding Value $3.54M 137,760 shares
Last Trade
Sep 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.71M 264,554 shares
$29.16
$25.69
Rocket Pharmaceuticals
Rocket Pharmaceuticals RCKT
Director
Holding Value $80.4k 27,545 shares
Last Trade
Sep 09, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$997k 50,533 shares
$19.73
$2.92
Agilent Technologies
Agilent Technologies A
Director
Holding Value $790k 5,711 shares
Last Trade
Mar 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$247k 1,678 shares
$147.48
$138.36
Pfizer
Pfizer PFE
President R&d
Holding Value $8.27M 321,729 shares
Last Trade
Feb 28, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$580k 21,437 shares
$27.04
$25.69
Pfizer
Pfizer PFE
President R&d
Holding Value $5.52M 214,880 shares
Last Trade
Feb 27, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9M 404,747 shares
$26.89
$25.69
Pfizer
Pfizer PFE
President R&d
Holding Value $8.82M 343,166 shares
Last Trade
Feb 23, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$689k 24,822 shares
$27.76
$25.69
Pfizer
Pfizer PFE
President R&d
Holding Value $2.25M 87,581 shares
Last Trade
Dec 15, 2023 Purchase (Discretionary)A discretionary transaction reported earlier than normally required.
$1M 37,552 shares
$26.63
$25.69
Agilent Technologies
Agilent Technologies A
Director
Holding Value $556k 4,018 shares
Last Trade
Mar 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$227k 1,658 shares
$136.82
$138.36
Pfizer
Pfizer PFE
President R&d
Holding Value $9.1M 354,145 shares
Last Trade
Feb 25, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.55M 37,078 shares
$41.75
$25.69
Pfizer
Pfizer PFE
President R&d
Holding Value $3.54M 137,760 shares
Last Trade
Feb 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.9M 257,654 shares
$42.30
$25.69
Pfizer
Pfizer PFE
President R&d
Holding Value $10.1M 391,223 shares
Last Trade
Feb 22, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.38M 32,592 shares
$42.38
$25.69

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up